The recall has been issued for some products due to higher than acceptable levels of benzene, a chemical linked to leukemia and other blood disorders.
While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...
15h
Clinical Trials Arena on MSNRoche’s discontinued Alzheimer’s drug shows signs of preventing onsetInvestigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing symptoms by 50%.
The FDA said testing of certain acne products with benzoyl peroxide found elevated levels of benzene, a chemical linked to cancer.
Angesichts des Drucks der Trump-Regierung hat der Schweizer Pharmariese Roche seine seit langem bestehenden globalen ...
Wells approved five beach parking changes including limiting the number of beach parking stickers to two per household.
Oxford Biotherapeutics Ltd. is partnering with Roche AG to expand the current field of tumor antigens that can be drugged with antibodies, as part of a potential $1 billion-plus agreement. The ...
Health tech company Flatiron Health, an independent affiliate of the Roche Group, is expanding the reach of its clinical data ...
Meanwhile, fellow Swiss company Novartis will no longer use diverse panels in its hiring process for U.S.-based employees, ...
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results